Science first. Every Zenithia formulation begins with evidence and ends with a rigorously tested medicine a doctor can prescribe with confidence.
Home › Research
From molecule selection to the pharmacy shelf — a disciplined, quality-gated journey.
We select molecules and combinations with established clinical evidence and proven therapeutic outcomes — like co-amoxiclav, azithromycin and pantoprazole-domperidone — prioritising what physicians actually need in the field.
Bioavailable salts, gastro-resistant coatings and prolonged-release matrices are chosen to improve absorption, tolerability and patient compliance — not just to fill a label.
Assay, dissolution, microbial and stability studies on every batch. Products are validated for Indian storage conditions — heat, humidity and long supply chains.
All products are manufactured at certified facilities following Good Manufacturing Practices — controlled environments, validated processes and full batch traceability.
Documented quality management across procurement, production, storage and distribution, audited and continually improved.
Our tablets and capsules conform to Indian Pharmacopoeia standards, with transparent labelling in English and Hindi for every strength and excipient.
We monitor product feedback from doctors, chemists and patients, and act quickly on every quality signal — because trust is earned batch after batch.
Our portfolio is built around the everyday realities of Indian clinical practice — infections, acidity, pain and nutritional gaps.
Innovation at Zenithia never stands still. Currently we are expanding our range in dermatology, paediatrics, gynaecology and other specialised segments. Watch this space — or ask our team about upcoming launches.
Our team is happy to share composition details, certificates and product literature.
Talk to Us →